Studies on the metabolic mechanisms in aspirin-induced thrombocytopathy.
D000255:Adenosine Triphosphate / Q000378:metabolism; D001241:Aspirin / Q000009:adverse effects*; D001667:Binding, Competitive; D001791:Blood Platelet Disorders / Q000139:chemically induced*; D001792:Blood Platelets / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002250:Carbon Radioisotopes; D002952:Citric Acid Cycle / Q000187:drug effects; D003653:Decarboxylation; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D006593:Hexokinase / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007773:Lactates / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011485:Protein Binding; D012459:Salicylates / Q000009:adverse effects; D012709:Serum Albumin / Q000378:metabolism; D013696:Temperature
D002250:Carbon Radioisotopes; D007773:Lactates; D012459:Salicylates; D012709:Serum Albumin; D000255:Adenosine Triphosphate; D006003:Glycogen; D006593:Hexokinase; D005947:Glucose; D001241:Aspirin